Pages that link to "Q48291146"

The following pages link to Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. (Q48291146):

Displaying 31 items.

• The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease (Q26768487) (← links)
• Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease (Q30497749) (← links)
• Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis (Q30583514) (← links)
• In vitro imaging techniques in neurodegenerative diseases (Q33275232) (← links)
• Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease (Q33520683) (← links)
• Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy (Q34421064) (← links)
• Neurological and psychiatric disorders as a neuroglial failure. (Q34770769) (← links)
• Translocation and potential neurological effects of fine and ultrafine particles a critical update (Q35040112) (← links)
• The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease (Q35327219) (← links)
• Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease (Q35754225) (← links)
• Imaging changes associated with cognitive abnormalities in Parkinson's disease (Q35797763) (← links)
• Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders (Q36118835) (← links)
• PATHOBIOLOGY OF NEURODEGENERATION: THE ROLE FOR ASTROGLIA. (Q36998893) (← links)
• Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice (Q37051783) (← links)
• Advances on the understanding of the origins of synaptic pathology in AD. (Q37108156) (← links)
• The use of PET in Alzheimer disease (Q37688880) (← links)
• Neuroglial roots of neurodegenerative diseases? (Q37821366) (← links)
• Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised (Q37971458) (← links)
• Cotinine: a potential new therapeutic agent against Alzheimer's disease. (Q38005188) (← links)
• Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry (Q38906604) (← links)
• Purinergic P2Y1 Receptors Control Rapid Expression of Plasma Membrane Processes in Hippocampal Astrocytes. (Q39672793) (← links)
• Evolution of neuronal changes in the course of Alzheimer’s disease (Q48413398) (← links)
• In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study (Q48943323) (← links)
• Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system (Q49019912) (← links)
• Advances in genetic models of Parkinson's disease (Q54965150) (← links)
• Inflammation as a central mechanism in Alzheimer's disease (Q58555818) (← links)
• Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease (Q64103399) (← links)
• Glutamine Improves Oxidative Stress through the Wnt3a/-Catenin Signaling Pathway in Alzheimer's Disease In Vitro and In Vivo (Q64107149) (← links)
• [Postmortal diagnosis of Parkinson's disease] (Q80989867) (← links)
• Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs (Q89505497) (← links)
• Strategies for the Treatment of Parkinson's Disease: Beyond Dopamine (Q89792742) (← links)